Search Results

Oral contraceptives and venous thromboembolism: identifying the safest option

Author: Wu, Olivia

Source: Expert Review of Cardiovascular Therapy, Volume 7, Number 12, December 2009 , pp. 1513-1516(4)

Publisher: Expert Reviews

Oral contraception usage in relation to bone mineral density and bone turnover in adolescent girls

Authors: Lattakova, M.; Borovsky, M.; Payer, J.; Killinger, Z.

Source: The European Journal of Contraception and Reproductive Health Care, Volume 14, Number 3, June 2009 , pp. 207-214(8)

Publisher: Informa Healthcare

The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism

Authors: Dikensoy, Ebru; Balat, Ozcan; Pence, Sadrettin; Akcali, Cenk; Cicek, Hulya

Source: Archives of Gynecology and Obstetrics, Volume 279, Number 3, March 2009 , pp. 321-327(7)

Publisher: Springer

Added Benefits and User Satisfaction with a Low-Dose Oral Contraceptive Containing Drospirenone: Results of Three Multicentre Trials

Authors: Bitzer, Johannes; Paoletti, Anna M.

Source: Clinical Drug Investigation, Volume 29, Number 2, 2009 , pp. 73-78(6)

Publisher: Adis International

Effect of two low-dose gestodene containing monophasic oral contraceptives on hemostasis in Bulgarian women

Authors: Uchikova, Ekaterina; Pehlivanov, Blagovest

Source: Expert Opinion on Pharmacotherapy, Volume 9, Number 11, August 2008 , pp. 1839-1844(6)

Publisher: Informa Healthcare

Pretreatments before the Induction of Ovulation in Assisted Reproduction Technologies: Evidence-based Medicine in 2007

Authors: Bromer, Jason Gabriel; Cetinkaya, Mehmet Bilge; Arici, Aydin

Source: Annals of the New York Academy of Sciences, Volume 1127, Number 1, April 2008 , pp. 31-40(10)

Publisher: Blackwell Publishing

Third-generation oral contraceptives: future implications of current use

Authors: Ouzounian, Sophie; Verstraete, Lieve; Chabbert-Buffet, Nathalie

Source: Expert Review of Obstretrics and Gynecology, Volume 3, Number 2, March 2008 , pp. 189-201(13)

Publisher: Expert Reviews

Contraception for obese women: challenges, concerns and recommendations for the future

Authors: Brunner Huber, Larissa R; Rowland Hogue, Carol J

Source: Expert Review of Obstretrics and Gynecology, Volume 2, Number 3, May 2007 , pp. 357-365(9)

Publisher: Expert Reviews

Clinical profile of 24-day oral contraceptives

Author: Speroff, Leon

Source: Expert Review of Obstretrics and Gynecology, Volume 2, Number 3, May 2007 , pp. 367-370(4)

Publisher: Expert Reviews

Therapeutic options in the polycystic ovary syndrome

Author: Bhathena, R. K.

Source: Journal of Obstetrics & Gynaecology, Volume 27, Number 2, 2007 , pp. 123-129(7)

Publisher: Informa Healthcare

Extended-cycle oral contraceptive pills with 10 µg ethinyl estradiol pills in place of placebo pills

Author: Nelson, Anita L

Source: Women's Health, Volume 3, Number 5, September 2007 , pp. 529-535(7)

Publisher: Future Medicine

Vulvar Vestibulitis Syndrome and Estrogen Dose of Oral Contraceptive Pills

Authors: Greenstein, Alexander; Ben-Aroya, Zahi; Fass, Orit; Militscher, Idan; Roslik, Yelena; Chen, Juza; Abramov, Liora

Source: The Journal of Sexual Medicine, Volume 4, Number 6, November 2007 , pp. 1679-1683(5)

Publisher: Blackwell Publishing

Drospirenone/Ethinylestradiol 3mg/20µg (24/4 Day Regimen): A Review of Its Use in Contraception, Premenstrual Dysphoric Disorder and Moderate Acne Vulgaris

Authors: Fenton, Caroline; Wellington, Keri; Moen, Marit D.; Robinson, Dean M.

Source: Drugs, Volume 67, Number 12, 2007 , pp. 1749-1765(17)

Publisher: Adis International

Drospirenone: a novel progestin

Authors: Rapkin, Andrea J; Winer, Sharon A

Source: Expert Opinion on Pharmacotherapy, Volume 8, Number 7, May 2007 , pp. 989-999(11)

Publisher: Informa Healthcare

Yasminelle^®: a new low-dose combined oral contraceptive containing drospirenone

Author: Sillem, Martin

Source: Women's Health, Volume 2, Number 4, July 2006 , pp. 551-559(9)

Publisher: Future Medicine

Low-dose ethinylestradiol/drospirenone effective oral contraceptive

Source: Inpharma, Volume 1, Number 1535, 2006-04-29 , pp. 6-6(1)

Publisher: Adis International

Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women

Authors: Ibáñez, Lourdes; de Zegher, Francis

Source: Human Reproduction Update, Volume 12, Number 3, May 2006 , pp. 243-252(10)

Publisher: Oxford University Press

A Comparison of the Cycle Control, Safety, and Efficacy Profile of a 21-Day Regimen of Ethinylestradiol 20μg and Drospirenone 3mg with a 21-Day Regimen of Ethinylestradiol 20μg and Desogestrel 150μg

Authors: Gruber, Doris M.; Huber, Johannes C.; Gian Benedetto Melis,; Stagg, Caroline; Parke, Susanne; Marr, Joachim

Source: Treatments in Endocrinology, Volume 5, Number 2, 2006 , pp. 115-121(7)

Publisher: Adis International

Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20µg and Drospirenone 3mg

Authors: Cibula, D.; Karck, U.; Weidenhammer, H.G.; Kunz, J.; Alincic, S.; Marr, J.

Source: Clinical Drug Investigation, Volume 26, Number 3, 2006 , pp. 143-150(8)

Publisher: Adis International

Discontinuous low-dose flutamide–metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-α and the neutrophil/lymphocyte ratio

Authors: Ibáñez, Lourdes; Valls, Carme; de Zegher, Francis

Source: Human Reproduction, Volume 21, Number 2, February 2006 , pp. 451-456(6)

Publisher: Oxford University Press